Drug intelligence / Profile preview

SLIMTRAX

Development stage: Unknown
Lead developer: Pharmessen
Modality: Small Molecules
Administration: Oral

Overview

SLIMTRAX is a proprietary nutraceutical weight-management supplement developed by Pharmessen Scientific. It consists of a blend of herbal essential oils, specifically clove, cinnamon, and ginger. The formulation is designed to reduce hunger and regulate blood glucose levels without the use of stimulants like ephedrine or caffeine. Its primary mechanisms include appetite suppression, activation of fat metabolism, and antioxidant effects. Developed by Dr. Dusan G. Ninkov, the product is marketed for weight reduction and body weight control.

Brand names: SLIMTRAX

Beyond the preview

Go deeper on SLIMTRAX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLIMTRAX.

Explore the full profile